Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment
Paclitaxel (PTX) injection (i.e., Taxol) has been used as an effective chemotherapeutic treatment for various cancers. However, the current Taxol formulation contains Cremophor EL, which causes hypersensitivity reactions during intravenous administration and precipitation by aqueous dilution. This c...
Saved in:
Main Authors: | Chowdhury, M.R., Moshikur, R.M., Wakabayashi, R., Tahara, Y., Kamiya, N., Moniruzzaman, M., Goto, M. |
---|---|
Format: | Article |
Published: |
American Chemical Society
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047431364&doi=10.1021%2facs.molpharmaceut.8b00305&partnerID=40&md5=1686ee767f2f2e0a8b5ead1d550a6ca9 http://eprints.utp.edu.my/20856/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment
by: Chowdhury, M.R., et al.
Published: (2018) -
Ionic-liquid-based paclitaxel preparation: a new potential formulation for cancer treatment
by: Chowdhury, Md Raihan, et al.
Published: (2018) -
In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations
by: Chowdhury, Md Raihan, et al.
Published: (2019) -
Biocompatible ionic liquid-mediated micelles for enhanced transdermal delivery of paclitaxel
by: Ali, Md Korban, et al.
Published: (2021) -
Ionic liquids with methotrexate moieties as a potential anticancer prodrug: Synthesis, characterization and solubility evaluation
by: Moshikur, R.M., et al.
Published: (2019)